For the dual and mono-agonists, SURMOUNT-1 (Jastreboff et al., 2022) and STEP 1 (Wilding et al., 2021) showed a consistent picture with predominantly mild to moderate gastrointestinal events
After an initial screening and consultation (including screening measures like the PHQ-9 and GAD-7), Nurxs providers will help you determine if medication is right for you
Nausea associated with GLP-1 receptor agonists typically occurs because these medications delay the rate at which food leaves the stomach (gastric emptying)
In the beginning, start out by trying to delay breakfast by a few hours or using a smaller fasting window (e.g., 12:12 with 12 hours of fasting and 12 hours of eating)
Semaglutide acts as an appetite suppressant, allowing patients to avoid overeating or indulging in unhealthy foods
3 All doses effectively reduced HbA1c and fasting blood glucose, with the 80 mg and 120 mg doses showing the greatest weight loss compared to placebo